Brief: Cyclopharm Says Technegas Awarded US Pass-Through Reimbursement Status
05/06/2024 02:29
June 5 (Reuters) - Cyclopharm Ltd CYC.AX :
* TECHNEGAS AWARDED US PASS-THROUGH REIMBURSEMENT STATUS
Further company coverage: CYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclopharm
See all newsAustralia's Cyclopharm rises after Chinese medical groups back its Technegas
Australia's Cyclopharm gains most in 8-months on Technegas rollout deal
Australia's Cyclopharm rises on HY revenue forecast
Brief: Cyclopharm Forecasts 1H Global Revenue Of A$17.1 Million
Brief: Cyclopharm Says David Heaney To Retire As Non-Executive Chair